Display options
Cite
Ann JY, Eo H, Lim Y. Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice. Genes Nutr. 2015;10(6):46doi: 10.1007/s12263-015-0495-x.
Ann, J. Y., Eo, H., & Lim, Y. (2015). Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice. Genes & nutrition, 10(6), 46. https://doi.org/10.1007/s12263-015-0495-x
Ann, Ji-Young, et al. "Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice." Genes & nutrition vol. 10,6 (2015): 46. doi: https://doi.org/10.1007/s12263-015-0495-x
Ann JY, Eo H, Lim Y. Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice. Genes Nutr. 2015 Nov;10(6):46. doi: 10.1007/s12263-015-0495-x. Epub 2015 Oct 13. PMID: 26463593; PMCID: PMC4604156.
Copy Download .nbib Format: NLM
Share it on

Genes Nutr. 2015 Nov;10(6):46. doi: 10.1007/s12263-015-0495-x. Epub 2015 Oct 13.

Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice.

Genes & nutrition

Ji-Young Ann, Hyeyoon Eo, Yunsook Lim

Affiliations

  1. Department of Food and Nutrition, Kyung Hee University, 26 Kyunghee-daero, Dongdaemun-gu, Seoul, 130-701, Republic of Korea.
  2. Department of Food and Nutrition, Kyung Hee University, 26 Kyunghee-daero, Dongdaemun-gu, Seoul, 130-701, Republic of Korea. [email protected].

PMID: 26463593 PMCID: PMC4604156 DOI: 10.1007/s12263-015-0495-x

Abstract

Obesity is associated with chronic diseases such as fatty liver, type 2 diabetes, cardiovascular disease, and severe metabolic syndrome. Obesity causes metabolic impairment including excessive lipid accumulation and fibrosis in the hepatic tissue as well as the increase in oxidative stress. In order to investigate the effect of mulberry leaf (Morus alba L.) extract (MLE) on obesity-induced oxidative stress, lipogenesis, and fibrosis in liver, MLE has been gavaged for 12 weeks in high-fat diet (HFD)-induced obese mice. MLE treatment significantly ameliorated LXRα-mediated lipogenesis and hepatic fibrosis markers such as α-smooth muscle actin, while MLE up-regulated lipolysis-associated markers such as lipoprotein lipase in the HFD-fed mice. Moreover, MLE normalized the activities of antioxidant enzymes including heme oxygenase-1 and glutathione peroxidase in accordance with protein levels of 4-hydroxynonenal in the HFD-fed mice. MLE has beneficial effects on obesity-related fatty liver disease by regulation of hepatic lipid metabolism, fibrosis, and antioxidant defense system. MLE supplementation might be a potential therapeutic approach for obesity-related disease including non-alcoholic fatty liver disease.

Keywords: Fatty liver; Hepatic lipid metabolism; Liver fibrosis; Mulberry leaf; Oxidative stress

References

  1. Life Sci. 2012 Oct 29;91(17-18):872-7 - PubMed
  2. Toxicol Appl Pharmacol. 2010 Apr 1;244(1):77-83 - PubMed
  3. Neurourol Urodyn. 2013 Jun;32(5):493-9 - PubMed
  4. J Sci Food Agric. 2011 Dec;91(15):2740-8 - PubMed
  5. Biochem Biophys Res Commun. 2004 Nov 26;324(4):1309-18 - PubMed
  6. J Biol Chem. 2000 Oct 6;275(40):31069-77 - PubMed
  7. Mol Cell Biol. 2004 Apr;24(8):3430-44 - PubMed
  8. J Med Food. 2013 Aug;16(8):673-80 - PubMed
  9. Free Radic Biol Med. 2013 Mar;56:226-33 - PubMed
  10. Gastroenterology. 2012 Sep;143(3):741-53.e1-4 - PubMed
  11. J Food Sci. 2008 Aug;73(6):H113-21 - PubMed
  12. Ann Clin Lab Sci. 2004 Winter;34(1):57-62 - PubMed
  13. Biochim Biophys Acta. 2013 Apr;1831(4):803-18 - PubMed
  14. J Orthop Res. 2010 Sep;28(9):1162-9 - PubMed
  15. Diabetes. 2015 Jul;64(7):2398-408 - PubMed
  16. J Agric Food Chem. 2009 Nov 25;57(22):11024-9 - PubMed
  17. J Hepatol. 2011 May;54(5):984-93 - PubMed
  18. Acta Physiol (Oxf). 2012 Mar;204(3):354-61 - PubMed
  19. J Gastroenterol. 2013 May;48(5):620-32 - PubMed
  20. Biol Pharm Bull. 2000 Sep;23(9):1066-71 - PubMed
  21. Drugs Today (Barc). 2006 Jan;42(1):39-64 - PubMed
  22. Endocrine. 2015 Apr;48(3):834-47 - PubMed
  23. Diabetes. 2013 Mar;62(3):845-54 - PubMed
  24. Mol Cell Biol. 2006 Jan;26(1):221-9 - PubMed
  25. Top Curr Chem. 2013;329:133-62 - PubMed
  26. Diabetes Metab J. 2014 Oct;38(5):337-45 - PubMed
  27. Cardiovasc Res. 2013 Oct 1;100(1):63-73 - PubMed
  28. Hepatology. 2012 Apr;55(4):1103-11 - PubMed
  29. BMB Rep. 2012 Jun;45(6):348-53 - PubMed
  30. J Biol Chem. 2007 Feb 23;282(8):5207-16 - PubMed
  31. Fitoterapia. 2006 Dec;77(7-8):579-84 - PubMed
  32. J Nat Med. 2012 Apr;66(2):333-42 - PubMed
  33. J Bone Joint Surg Am. 2012 Feb 1;94(3):201-7 - PubMed
  34. Biol Pharm Bull. 2012;35(3):273-9 - PubMed
  35. Yonsei Med J. 2001 Feb;42(1):1-8 - PubMed
  36. PLoS One. 2009 Aug 27;4(8):e6796 - PubMed
  37. Drug Chem Toxicol. 2012 Oct;35(4):445-9 - PubMed
  38. Exp Biol Med (Maywood). 2013 Oct;238(10):1160-9 - PubMed
  39. J Agric Food Chem. 2012 Sep 12;60(36):9180-7 - PubMed
  40. Diabetes. 2012 Dec;61(12 ):3208-18 - PubMed
  41. Biomed Res Int. 2013;2013:787981 - PubMed
  42. Curr Opin Lipidol. 1999 Jun;10(3):245-57 - PubMed
  43. Mol Pharmacol. 2013 Jul;84(1):62-70 - PubMed
  44. Diabetes. 2002 Apr;51(4):901-9 - PubMed
  45. Acta Biochim Biophys Sin (Shanghai). 2013 Feb;45(2):95-103 - PubMed
  46. Biosci Biotechnol Biochem. 2010;74(12):2385-95 - PubMed
  47. Antioxid Redox Signal. 2011 Mar 15;14 (6):957-71 - PubMed
  48. Arch Toxicol. 2013 Feb;87(2):383-96 - PubMed
  49. Toxicol Appl Pharmacol. 2012 Nov 1;264(3):305-14 - PubMed
  50. Phytother Res. 2008 Oct;22(10):1367-71 - PubMed
  51. J Agric Food Chem. 2011 Mar 23;59(6):2663-71 - PubMed
  52. Int J Hepatol. 2012;2012:925807 - PubMed

Publication Types